Day 2 of CHDI’s HD therapeutics conference: figuring out energy problems in HD
Day 1 of CHDI’s HD therapeutics conference: exploring abnormal brain connections and silencing the HD gene
Anti-nausea drug meclizine protects cells with the HD mutation from death by reducing cellular energy production
Memantine, a drug already used in Alzheimer’s disease, might help in HD, but a mouse study shows dose is everything.
Dimebon – disappointing results in an Alzheimer’s disease trial, but hope remains for HD.
DOMINO clinical trial result: minocycline doesn’t slow down HD and shouldn’t be studied in larger trials.